Source:http://linkedlifedata.com/resource/pubmed/id/15625277
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-3-22
|
pubmed:abstractText |
Although potentially implicated in several physiological functions, few functional mutations have been identified in the human 5-hydroxytryptamine (HT)(2B) receptor gene. A heterozygous mutation R393X in the 5-HT(2B) receptor was recently identified in a patient diagnosed with pulmonary hypertension after intake of the anorexigenic dexfenfluramine. Although reported to generate a lack of function, this C terminus-truncated 5-HT(2B) receptor should somehow affect transduction pathways relevant to pulmonary hypertension. In our study, we investigated putative modifications in transduction of the R393X-mutated 5-HT(2B) receptor. In stably transfected cells, we confirmed the loss of inositol 1,4,5-trisphosphate stimulation caused by the G(alphaq) uncoupling, despite conserved ligand affinity between the normal and mutated receptors. We also observed a partial loss of nitric-oxide synthase stimulation. However, the truncated R393X receptor presented 1) a strong gain of efficacy in cell proliferation as assessed by mitogen-activated protein kinase activity and thymidine incorporation, 2) a preferential coupling to G(alpha13) as shown by blocking antiserum, and 3) an apparent lack of internalization upon agonist stimulation as observed by confocal microscopy. This work demonstrates that, in the 5-HT(2B) receptor, the C terminus, including the palmitoylation and phosphorylation sites, is absolutely required for proper transduction and internalization. For the first time, we show that the lack of C terminus can generate a switch of coupling to G(alpha13), a reduced NO synthase activation, and an increase in cell proliferation. All these modifications are relevant in pathophysiological vasoconstriction.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/NOS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT2B
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0026-895X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
983-91
|
pubmed:dateRevised |
2011-10-27
|
pubmed:meshHeading |
pubmed-meshheading:15625277-Cell Line,
pubmed-meshheading:15625277-Cell Proliferation,
pubmed-meshheading:15625277-Enzyme Activation,
pubmed-meshheading:15625277-Humans,
pubmed-meshheading:15625277-Mitogen-Activated Protein Kinases,
pubmed-meshheading:15625277-Mutation,
pubmed-meshheading:15625277-Nitric Oxide Synthase,
pubmed-meshheading:15625277-Nitric Oxide Synthase Type II,
pubmed-meshheading:15625277-Protein Conformation,
pubmed-meshheading:15625277-Receptor, Serotonin, 5-HT2B,
pubmed-meshheading:15625277-Structure-Activity Relationship
|
pubmed:year |
2005
|
pubmed:articleTitle |
The natural mutation encoding a C terminus-truncated 5-hydroxytryptamine 2B receptor is a gain of proliferative functions.
|
pubmed:affiliation |
INSERM U616 Hospital Pitié-Salpetrière, Batiment Pédiatrie, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|